1. Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma
   Karina Galoian et al, 2016 CrossRef
2. Epigenetic control of cancer by neuropeptides
   Karina Galoian et al, 2017 CrossRef
3. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms
   Shao-Yao Ying et al, 2018 CrossRef
4. MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma
   Feifei Pu et al, 2016, Tumor Biol. CrossRef
5. Application of the microRNA‐302/367 cluster in cancer therapy
   Jiajia Liu et al, 2020, Cancer Sci CrossRef
6. Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.
   Karina Galoian et al, 0 CrossRef
7. HOXA-AS2 promotes type I endometrial carcinoma via miRNA-302c-3p-mediated regulation of ZFX
   Ning Song et al, 2020, Cancer Cell Int CrossRef
8. Preliminary screening of fluorine‐stained osteoblastic apoptosis‐related microRNA
   Qiang Deng et al, 2021, Anat Rec CrossRef
9. ВЛИЯНИЕ PRP-1 НА НЕЙРОННУЮ АКТИВНОСТЬ ЛАТЕРАЛЬНОГО ВЕСТИБУЛЯРНОГО ЯДРА У КРЫС / THE EFFECTS OF PRP-1 ON THE NEURONAL ACTIVITY OF THE LATERAL VESTIBULAR NUCLEUS IN RATS
   Lilia Hambardzumyan et al, 2022 CrossRef
10. PRP-1, a toll-like receptor ligand, upregulates the unfolded protein response in human chondrosarcoma cells
    Karina Galoian et al, 2022, Cancer Treatment and Research Communications CrossRef
11. Diverse Effects of Hypothalamic Proline-Rich Peptide (PRP-1) on Cell Death in Neurodegenerative and Cancer Diseases
    Silva Abrahamyan et al, 2022 CrossRef
12. Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review
    Maria Angeles Chico et al, 2023, Cancers CrossRef
13. Targeting cancer stem cells by TPA leads to inhibition of refractory sarcoma and extended overall survival
    Karina Galoian et al, 2024, Molecular Therapy: Oncology CrossRef